# BN Agrochem share price today (BN Agrochem Ltd, NSE: BNAGROCHEM)

> BN Agrochem share price today: ₹113.30 at the NSE close on 30 October 2026, down 69.8% in a year. BN Agrochem (NSE: BNAGROCHEM) trades at a P/E of 63.0 and has closed between ₹113.30 and ₹406.50 over the past 52 weeks. > BN Agrochem Ltd's P/E is near the low end of its own history, higher than only 33% of past readings, and its quarterly results are still getting worse. BNAGROCHEM · Trading · data as of 30 October 2026. Page: https://www.sectoralpha.in/stocks/bn-agrochem-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹113.30 (−69.8% in a year)
- P/E: 63.0× (lower than 67% of the last 1 year)
- Revenue (Jun 2026): ₹258 Cr (+26.7% on a year ago)
- Profit (Jun 2026): ₹3.0 Cr (−85.2% on a year ago)
- Operating margin: 2.3% (−9.4 points on a year ago)
- ROCE: 4%, FY26
- ROIC: 0.7%, against a 12.0% cost of capital: −11.3 points
- Profit that came in as cash: −26%, last 2 years

The main question: yearly earnings per share moved +74.3% while the share price moved −69.8%. ## What is the BN Agrochem share price today? BN Agrochem Ltd's share price was ₹113.30 at the close on 30 October 2026. It has been falling for 12 weeks. That is 54.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹113 and ₹407, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 20 weeks running. Over the last 7.7 years the share price moved +405% while the NIFTY 500 moved +146%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 1 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at BN Agrochem this quarter? 4 points on a year earlier. 1. Operating margin down 9.4 points on a year earlier 2.3% in the June 2026 quarter, from 11.7%. ## What are BN Agrochem's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), BN Agrochem reported revenue of ₹258 crore, up 26.7% from ₹203 crore a year earlier, and a profit of ₹2.98 crore, down 85.2% from ₹20.1 crore. ### BN Agrochem results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹258 crore | ₹203 crore | +26.7% |
| Profit | ₹2.98 crore | ₹20.1 crore | −85.2% |
| Earnings per share | ₹0.30 | ₹2.05 | −85.4% |
| Operating margin | 2.3% | 11.7% | −9.4 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the BN Agrochem share price history? BN Agrochem closed at ₹113.30 on 30 October 2026, down 69.8% from ₹374.95 a year earlier (31 October 2025) and up 2,058.1% over five years. Its highest weekly close since February 2019 was ₹406.50 on 7 November 2025. ### BN Agrochem share price: then and now

| When | Close | Change to 30 Oct 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹146.25 | −22.5% |
| 1 month ago · 1 Oct 2026 | ₹230.00 | −50.7% |
| 6 months ago · 30 Apr 2026 | ₹238.10 | −52.4% |
| 1 year ago · 31 Oct 2025 | ₹374.95 | −69.8% |
| 3 years ago · 30 Oct 2023 | ₹59.13 | +91.6% |
| 5 years ago · 29 Oct 2021 | ₹5.25 | +2,058.1% |
| Earliest weekly close in our records · 6 Feb 2019 | ₹22.45 | +404.7% |
| Highest weekly close since February 2019, also the 52-week high · 7 Nov 2025 | ₹406.50 | −72.1% |
| Lowest weekly close since February 2019 · 22 Oct 2021 | ₹5.25 | +2,058.1% |
| 52-week low (weekly close) · 30 Oct 2026 | ₹113.30 | 0.0% |

Weekly closing prices. Each change is the move from that price to the 30 Oct 2026 close. A day's intraday high or low can go beyond these weekly closes. (300 weekly closes from 6 February 2019 to 30 October 2026.)

## What is the latest news on BN Agrochem? 30 Oct 2026: BN Agrochem closed at ₹113.30, down 22.5% on the week and down 50.7% on the month. Results for April to June 2026: Revenue up 26.7% and profit down 85.2% on a year earlier. ## What dividend does BN Agrochem pay? BN Agrochem has paid no dividend on the NSE since 1 April 2021, the start of the period we checked. No. BN Agrochem Ltd paid out 0% of its profit as dividends in each of its last 4 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is BN Agrochem on? BN Agrochem is not on any of our India lists this week. ## Is BN Agrochem profitable? BN Agrochem Ltd earned ₹3.0 Cr of net profit in the Jun 2026 quarter, −85.2% on the same quarter a year earlier. Full-year FY26 profit was ₹34.0 Cr. That is 1.2% of the quarter's revenue. The same quarter a year earlier earned ₹20.1 Cr. 6 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹34.0 Cr (+70.0% on the year before). Why profit moved: revenue changed +26.7% on a year earlier and the margin moved −9.4 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −112.4% and revenue +58.0%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does BN Agrochem make, and is it growing? BN Agrochem Ltd reported ₹258 Cr of revenue in the Jun 2026 quarter, +26.7% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. The last full year, FY26, came in at ₹873 Cr. The last four reported quarters add to ₹927 Cr. A growth rate over several years is not shown, because there are too few years of figures to work one out properly. FY26 revenue was ₹873 Cr, +192.0% on the year before. Is growth speeding up? Revenue over the last 12 months grew +84.5%, against +1,043.7% a year over the last 8 quarters (rolling over). ## How much of every ₹100 of sales does BN Agrochem keep? BN Agrochem Ltd's operating margin was 2.3% in the Jun 2026 quarter, 9.4 percentage points lower than the same quarter a year ago. Across 3 years it has been between −44.0% and 2.6%. The latest quarter is within that range. Why the margin moved: operating margin changed −9.4 percentage points on the year while gross margin changed −9.7 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is BN Agrochem's profit turning into cash? Over the last 2 years BN Agrochem Ltd's operations used more cash than they brought in, so cash conversion was −26%, a gap worth watching. In FY26 it brought in ₹24.0 Cr of operating cash against ₹34.0 Cr of profit. After ₹1.0 Cr of spending on assets, ₹23.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why −26% of profit came in as cash: the cash cycle got 59 days longer between FY24 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 59 days longer. The next section looks at where the cash is stuck. ## Where does BN Agrochem's cash go? BN Agrochem Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 59 days in FY26, up from 0 days in FY24. It spent ₹2.0 Cr on assets over the last 3 years. Customers take 59 days to pay, and stock sits for 0 days on average. At FY26 sales of ₹873 Cr, each day of that cycle ties up about ₹2.4 Cr, so roughly ₹141 Cr is tied up in the business at any time. FY26: customers took 59 days to pay and stock sat for 0 days, about 0.0 months of sales sitting as stock, for a full cycle of 59 days, longer than FY24's 0. Spending on assets: ₹2.0 Cr over the last 3 years, against ₹1.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is BN Agrochem's P/E ratio, and how does it compare with its own history? BN Agrochem Ltd's P/E is 63.0×, near the low end of its own history: it has been lower only 33% of the time. Its usual P/E (the middle reading) is 78.2×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +74.3% while the price moved −69.8%. Earnings did better than the price, which pulled the multiple down within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the BN Agrochem business getting better or worse? BN Agrochem Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 6 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does BN Agrochem earn on its capital? BN Agrochem Ltd earned a ROCE of 4% in FY26. That is up from a low of −9% in FY24. Its return on capital used (ROIC) is 11.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 3.9% net margin and 1.66× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 3.9% net margin × 1.66× asset turnover × 1.13× leverage (assets divided by equity) ≈ 7.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 0.7% − 12.0% = −11.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 0.7% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 5.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does BN Agrochem have too much debt? BN Agrochem Ltd has total debt of ₹51.0 Cr against shareholder equity of ₹467 Cr as of Jun 2026, so its debt is 0.11× its equity, which is very little. So the returns on this page come from the business, not from borrowed money. ## What is the BN Agrochem shareholding pattern? Promoters cut their stake in BN Agrochem Ltd by 52.7 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 5.9% of the company. Foreign institutions moved +0.0 points over the same period, to 0.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Promoters own under 20%, so this is a widely owned company where institutions, not a family, have the most say. Why the owners changed: promoters drove it (−52.7 points). They reduced their stake. ## How far is BN Agrochem from balance-sheet trouble? For BN Agrochem Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does BN Agrochem rank in its industry? 34.1 out of 100, rank 40 of 63 in Trading, with 64% of the evidence available. BN Agrochem Ltd scores 34.1 out of 100 against the 63 companies it is compared with in Trading, ranking 40. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 9.6 + 7.4 + 9.5 + 7.6 = 34.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is BN Agrochem compared with? BN Agrochem ranks 40 of 63 Trading companies on the 4-Factor Sector Score, with 34.1 out of 100. 1. [Mangalam Global Enterprise Ltd](https://www.sectoralpha.in/stocks/mangalam-global-enterprise-ltd) MGEL · turning · Most evidence points up · 93% evidence 70.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.5/35 · Revenue 44.2% · Profit 8.2% · Operating margin change 0.7 points · 100% evidence Capital efficiency 14.6/25 · ROCE 17% · Operating margin 2.3% · 100% evidence Valuation 15.8/20 · P/E 14.6× · PEG 0.31 · 65% evidence Relative strength 17.2/20 · Lead over its industry 12.9% · Lead over NIFTY 500 25.7% · 1 year 18.7% · 100% evidence · 5 of 12 weeks ahead Exact sum: 22.5 + 14.6 + 15.8 + 17.2 = 70.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Shankara Buildpro Ltd](https://www.sectoralpha.in/stocks/shankara-buildpro-ltd) BUILDPRO · quiet · Too little evidence to rank firmly · 59% evidence 64.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/43.75 · Revenue 26.3% · Profit 41.9% · Operating margin change -0.2 points · 88% evidence Capital efficiency 21.5/31.25 · ROCE 39% · Operating margin 3.2% · 100% evidence Valuation 13.4/25 · P/E 16× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 30 + 21.5 + 13.4 = 64.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 3. [Ivalue Infosolutions Ltd](https://www.sectoralpha.in/stocks/ivalue-infosolutions-ltd) IVALUE · quiet · Evidence leans up · 74% evidence 64.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 5.4% · Profit 22.1% · Operating margin change 5.6 points · 88% evidence Capital efficiency 19.8/25 · ROCE 25.4% · Operating margin 10% · 100% evidence Valuation 15.7/20 · P/E 10× · PEG 0.43 · 65% evidence Relative strength 8.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -18.6% · 1 year -31.1% · 25% evidence · 3 of 12 weeks ahead Exact sum: 20.7 + 19.8 + 15.7 + 8.1 = 64.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Maxgrow India Ltd](https://www.sectoralpha.in/stocks/maxgrow-india-ltd) Too little evidence to rank firmly · 53% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.9/35 · Revenue 100% · Profit 100% · Operating margin change 0.8 points · 62% evidence Capital efficiency 16.4/25 · ROCE 23.5% · Operating margin 2.7% · 95% evidence Valuation 11.5/20 · P/E 1.2× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 136% · 1 year n/a · 25% evidence Exact sum: 23.9 + 16.4 + 11.5 + 12.4 = 64.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [Nupur Recyclers Ltd](https://www.sectoralpha.in/stocks/nupur-recyclers-ltd) NRL · leader · Evidence leans up · 78% evidence 63.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.0/35 · Revenue 40.6% · Profit 29.8% · Operating margin change 3.6 points · 83% evidence Capital efficiency 15.3/25 · ROCE 15.1% · Operating margin 11.6% · 76% evidence Valuation 7.6/20 · P/E 64.4× · PEG n/a · 50% evidence Relative strength 19.9/20 · Lead over its industry 86.1% · Lead over NIFTY 500 100.5% · 1 year 134.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 21 + 15.3 + 7.6 + 19.9 = 63.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Arisinfra Solutions Ltd](https://www.sectoralpha.in/stocks/arisinfra-solutions-ltd) ARIS · breaking out · Too little evidence to rank firmly · 56% evidence 61.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.5/35 · Revenue 45.3% · Profit 100% · Operating margin change 2 points · 83% evidence Capital efficiency 13.5/25 · ROCE 15.6% · Operating margin 11% · 76% evidence Valuation 10.7/20 · P/E 17.2× · PEG n/a · 15% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 16.6% · 1 year -14.9% · 25% evidence · 11 of 12 weeks ahead Exact sum: 26.5 + 13.5 + 10.7 + 10.9 = 61.6 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [Bhatia Communications & Retail (India) Ltd](https://www.sectoralpha.in/stocks/bhatia-communications-retail-indialtd) Evidence leans up · 68% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.7/35 · Revenue 49% · Profit 45.5% · Operating margin change 0.3 points · 83% evidence Capital efficiency 18.4/25 · ROCE 21.3% · Operating margin 5.3% · 95% evidence Valuation 9.2/20 · P/E 22.8× · PEG n/a · 50% evidence Relative strength 11.5/20 · Lead over its industry n/a · Lead over NIFTY 500 30.1% · 1 year n/a · 25% evidence Exact sum: 21.7 + 18.4 + 9.2 + 11.5 = 60.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [DC Infotech & Communication Ltd](https://www.sectoralpha.in/stocks/dc-infotech-communication-ltd) DCI · breaking out · Evidence leans up · 81% evidence 60.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue 29.1% · Profit 41.9% · Operating margin change 0.4 points · 88% evidence Capital efficiency 16.5/25 · ROCE 23% · Operating margin 4.8% · 100% evidence Valuation 13.4/20 · P/E 24.6× · PEG 0.82 · 100% evidence Relative strength 11.1/20 · Lead over its industry n/a · Lead over NIFTY 500 20.1% · 1 year n/a · 25% evidence · 6 of 6 weeks ahead Exact sum: 19.3 + 16.5 + 13.4 + 11.1 = 60.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [SG Mart Ltd](https://www.sectoralpha.in/stocks/sg-mart-ltd) SGMART · leader · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 9.7% · Profit 26.7% · Operating margin change 3 points · 100% evidence Capital efficiency 11.6/25 · ROCE 10.2% · Operating margin 4.6% · 100% evidence Valuation 7.9/20 · P/E 71.1× · PEG 1.81 · 65% evidence Relative strength 18.3/20 · Lead over its industry 47.1% · Lead over NIFTY 500 60.5% · 1 year 146.8% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.3 + 11.6 + 7.9 + 18.3 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Tembo Global Industries Ltd](https://www.sectoralpha.in/stocks/tembo-global-industries-ltd) TEMBO · losing its lead · Evidence leans up · 71% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.6/35 · Revenue 34% · Profit 55.7% · Operating margin change 5 points · 83% evidence Capital efficiency 19.6/25 · ROCE 22.8% · Operating margin 16% · 76% evidence Valuation 11.2/20 · P/E 9.3× · PEG n/a · 15% evidence Relative strength 7.0/20 · Lead over its industry -19.2% · Lead over NIFTY 500 -8.7% · 1 year -20.8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.6 + 19.6 + 11.2 + 7 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Rashi Peripherals Ltd](https://www.sectoralpha.in/stocks/rashi-peripherals-ltd) RPTECH · losing its lead · Evidence leans up · 78% evidence 59.3 out of 100 Growth Capital Valuation Relative
12. [Sudarshan Pharma Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-pharma-industries-ltd) SUDARSHAN · turning · Evidence leans up · 85% evidence 58.7 out of 100 Growth Capital Valuation Relative
13. [Singer India Ltd](https://www.sectoralpha.in/stocks/singer-india-ltd) SINGERIND · Evidence leans up · 61% evidence 58.0 out of 100 Growth Capital Valuation Relative
14. [Euro Pratik Sales Ltd](https://www.sectoralpha.in/stocks/euro-pratik-sales-ltd) EUROPRATIK · quiet · Evidence leans up · 64% evidence 57.5 out of 100 Growth Capital Valuation Relative
15. [Pramara Promotions Ltd](https://www.sectoralpha.in/stocks/pramara-promotions-ltd) PRAMARA · Too little evidence to rank firmly · 52% evidence 54.6 out of 100 Growth Capital Valuation Relative
16. [State Trading Corporation of India Ltd](https://www.sectoralpha.in/stocks/state-trading-corporation-of-india-ltd) STCINDIA · quiet · Too little evidence to rank firmly · 57% evidence 53.4 out of 100 Growth Capital Valuation Relative
17. [Patel Retail Ltd](https://www.sectoralpha.in/stocks/patel-retail-ltd) PATELRMART · turning · Evidence leans up · 64% evidence 53.2 out of 100 Growth Capital Valuation Relative
18. [Yogi Ltd](https://www.sectoralpha.in/stocks/yogi-ltd) YOGI · quiet · Evidence leans up · 64% evidence 51.2 out of 100 Growth Capital Valuation Relative
19. [Transchem Ltd](https://www.sectoralpha.in/stocks/transchem-ltd) TRANSCHEM · Too little evidence to rank firmly · 52% evidence 51.0 out of 100 Growth Capital Valuation Relative
20. [Prostarm Info Systems Ltd](https://www.sectoralpha.in/stocks/prostarm-info-systems-ltd) PROSTARM · breaking out · Evidence leans up · 64% evidence 50.8 out of 100 Growth Capital Valuation Relative
21. [Dhunseri Ventures Ltd](https://www.sectoralpha.in/stocks/dhunseri-ventures-ltd) DVL · breaking out · Evidence leans up · 78% evidence 50.6 out of 100 Growth Capital Valuation Relative
22. Bizotic Commercial Ltd losing its lead · Evidence leans up · 63% evidence 50.5 out of 100 Growth Capital Valuation Relative
23. BMW Ventures Ltd BMW · Too little evidence to rank firmly · 51% evidence 50.2 out of 100 Growth Capital Valuation Relative
24. [Cropster Agro Ltd](https://www.sectoralpha.in/stocks/cropster-agro-ltd) quiet · Evidence leans down · 65% evidence 49.1 out of 100 Growth Capital Valuation Relative
25. [MMTC Ltd](https://www.sectoralpha.in/stocks/mmtc-ltd) MMTC · quiet · Evidence leans down · 92% evidence 47.2 out of 100 Growth Capital Valuation Relative
26. [Shiv Aum Steels Ltd](https://www.sectoralpha.in/stocks/shiv-aum-steels-ltd) SHIVAUM · breaking out · Evidence leans down · 63% evidence 46.8 out of 100 Growth Capital Valuation Relative
27. [Blue Pearl Agriventures Ltd](https://www.sectoralpha.in/stocks/blue-pearl-agriventures-ltd) BPAGRI · Too little evidence to rank firmly · 51% evidence 43.8 out of 100 Growth Capital Valuation Relative
28. [Lloyds Enterprises Ltd](https://www.sectoralpha.in/stocks/lloyds-enterprises-ltd) LLOYDSENT · quiet · Evidence leans down · 71% evidence 43.1 out of 100 Growth Capital Valuation Relative
29. [Hexa Tradex Ltd](https://www.sectoralpha.in/stocks/hexa-tradex-ltd) HEXATRADEX · breaking out · Evidence leans down · 64% evidence 39.9 out of 100 Growth Capital Valuation Relative
30. [Shanti Overseas (India) Ltd](https://www.sectoralpha.in/stocks/shanti-overseas-indialtd) SHANTI · Evidence leans down · 61% evidence 39.3 out of 100 Growth Capital Valuation Relative
31. [Riddhi Siddhi Gluco Biols Ltd](https://www.sectoralpha.in/stocks/riddhi-siddhi-gluco-biols-ltd) turning · Evidence leans down · 83% evidence 38.9 out of 100 Growth Capital Valuation Relative
32. [Hardwyn India Ltd](https://www.sectoralpha.in/stocks/hardwyn-india-ltd) HARDWYN · basing · Evidence leans down · 86% evidence 38.8 out of 100 Growth Capital Valuation Relative
33. [Adani Enterprises Ltd](https://www.sectoralpha.in/stocks/adani-enterprises-ltd) ADANIENT · quiet · Evidence leans down · 93% evidence 38.1 out of 100 Growth Capital Valuation Relative
34. [PTC India Ltd](https://www.sectoralpha.in/stocks/ptc-india-ltd) PTC · quiet · Evidence leans down · 78% evidence 37.4 out of 100 Growth Capital Valuation Relative
35. [Le Merite Exports Ltd](https://www.sectoralpha.in/stocks/le-merite-exports-ltd) LEMERITE · Too little evidence to rank firmly · 59% evidence 36.8 out of 100 Growth Capital Valuation Relative
36. [Fabtech Technologies Ltd](https://www.sectoralpha.in/stocks/fabtech-technologies-ltd) FABTECH · quiet · Evidence leans down · 68% evidence 36.7 out of 100 Growth Capital Valuation Relative
37. [Uniphos Enterprises Ltd](https://www.sectoralpha.in/stocks/uniphos-enterprises-ltd) UNIENTER · turning · Too little evidence to rank firmly · 59% evidence 35.7 out of 100 Growth Capital Valuation Relative
38. Manbro Industries Ltd Too little evidence to rank firmly · 57% evidence 35.3 out of 100 Growth Capital Valuation Relative
39. Shah Foods Ltd quiet · Too little evidence to rank firmly · 53% evidence 35.3 out of 100 Growth Capital Valuation Relative
40. BN Agrochem Ltd this page BNAGROCHEM · quiet · Most evidence points down · 64% evidence 34.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.6/35 · Revenue 84.5% · Profit -61% · Operating margin change -9.4 points · 88% evidence Capital efficiency 7.4/25 · ROCE 4.4% · Operating margin 2.3% · 100% evidence Valuation 9.5/20 · P/E 63× · PEG n/a · 15% evidence Relative strength 7.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -56.9% · 1 year -69.8% · 25% evidence · 0 of 12 weeks ahead Exact sum: 9.6 + 7.4 + 9.5 + 7.6 = 34.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 41. [Neueon Corporation Ltd](https://www.sectoralpha.in/stocks/neueon-corporation-ltd) NEUEON · quiet · Too little evidence to rank firmly · 56% evidence 33.3 out of 100 Growth Capital Valuation Relative
42. [Kothari Industrial Corporation Ltd](https://www.sectoralpha.in/stocks/kothari-industrial-corporation-ltd) KOTIC · quiet · Too little evidence to rank firmly · 53% evidence 32.9 out of 100 Growth Capital Valuation Relative
43. [Oswal Agro Mills Ltd](https://www.sectoralpha.in/stocks/oswal-agro-mills-ltd) OSWALAGRO · Too little evidence to rank firmly · 52% evidence 28.6 out of 100 Growth Capital Valuation Relative
44. [Susan Electricals India Ltd](https://www.sectoralpha.in/stocks/susan-electricals-india-ltd) quiet · Too little evidence to rank firmly · 36% evidence 61.2 out of 100 Growth Capital Valuation Relative
45. [Magnus Steel & Infra Ltd](https://www.sectoralpha.in/stocks/magnus-steel-infra-ltd) Too little evidence to rank firmly · 40% evidence 61.1 out of 100 Growth Capital Valuation Relative
46. [Vision Infra Equipment Solutions Ltd](https://www.sectoralpha.in/stocks/vision-infra-equipment-solutions-ltd) VIESL · breaking out · Too little evidence to rank firmly · 47% evidence 58.5 out of 100 Growth Capital Valuation Relative
47. [Q-Line Biotech Ltd](https://www.sectoralpha.in/stocks/q-line-biotech-ltd) QLINE · losing its lead · Too little evidence to rank firmly · 21% evidence 57.8 out of 100 Growth Capital Valuation Relative
48. Aayush Art and Bullion Ltd breaking out · Too little evidence to rank firmly · 48% evidence 57.1 out of 100 Growth Capital Valuation Relative
49. [HP Telecom India Ltd](https://www.sectoralpha.in/stocks/hp-telecom-india-ltd) HPTL · Too little evidence to rank firmly · 32% evidence 57.1 out of 100 Growth Capital Valuation Relative
50. [SK Minerals & Additives Ltd](https://www.sectoralpha.in/stocks/sk-minerals-additives-ltd) quiet · Too little evidence to rank firmly · 43% evidence 55.9 out of 100 Growth Capital Valuation Relative
51. [Aptus Pharma Ltd](https://www.sectoralpha.in/stocks/aptus-pharma-ltd) Too little evidence to rank firmly · 41% evidence 55.6 out of 100 Growth Capital Valuation Relative
52. [Mardia Samyoung Capillary Tubes Company Ltd](https://www.sectoralpha.in/stocks/mardia-samyoung-capillary-tubes-company-ltd) MSCTC · Too little evidence to rank firmly · 26% evidence 55.3 out of 100 Growth Capital Valuation Relative
53. [Proventus Agrocom Ltd](https://www.sectoralpha.in/stocks/proventus-agrocom-ltd) PROV · breaking out · Too little evidence to rank firmly · 39% evidence 54.1 out of 100 Growth Capital Valuation Relative
54. [Pervasive Commodities Ltd](https://www.sectoralpha.in/stocks/pervasive-commodities-ltd) breaking out · Too little evidence to rank firmly · 48% evidence 51.8 out of 100 Growth Capital Valuation Relative
55. [Monika Alcobev Ltd](https://www.sectoralpha.in/stocks/monika-alcobev-ltd) MONIKA · Too little evidence to rank firmly · 27% evidence 49.9 out of 100 Growth Capital Valuation Relative
56. [Onix Solar Energy Ltd](https://www.sectoralpha.in/stocks/onix-solar-energy-ltd) ONIXSOLAR · quiet · Too little evidence to rank firmly · 47% evidence 45.8 out of 100 Growth Capital Valuation Relative
57. Arvaya Healthcare Ltd ARVAYA · quiet · Too little evidence to rank firmly · 46% evidence 45.4 out of 100 Growth Capital Valuation Relative
58. [A-1 Ltd](https://www.sectoralpha.in/stocks/a-1-ltd) A1L · Too little evidence to rank firmly · 33% evidence 45.3 out of 100 Growth Capital Valuation Relative
59. [Satani Bearings Ltd](https://www.sectoralpha.in/stocks/satani-bearings-ltd) breaking out · Too little evidence to rank firmly · 42% evidence 42.9 out of 100 Growth Capital Valuation Relative
60. [Keto Motors Ltd](https://www.sectoralpha.in/stocks/keto-motors-ltd) quiet · Too little evidence to rank firmly · 42% evidence 40.9 out of 100 Growth Capital Valuation Relative
61. [Aerpace Industries Ltd](https://www.sectoralpha.in/stocks/aerpace-industries-ltd) breaking out · Too little evidence to rank firmly · 36% evidence 37.9 out of 100 Growth Capital Valuation Relative
62. [Prabhatam Infra Venture Ltd](https://www.sectoralpha.in/stocks/prabhatam-infra-venture-ltd) PRABHATAM · Too little evidence to rank firmly · 22% evidence 36.8 out of 100 Growth Capital Valuation Relative
63. [RRP Semiconductor Ltd](https://www.sectoralpha.in/stocks/rrp-semiconductor-ltd) RRP · Too little evidence to rank firmly · 42% evidence 34.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Trading](https://www.sectoralpha.in/sectors/trading), all 63 compared on one page. ## Which companies are close to BN Agrochem in size? BN Agrochem is the 18th largest of 59 Trading companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Arisinfra Solutions, Nupur Recyclers and Ivalue Infosolutions. Just below it: Pervasive Commodities, Tembo Global Industries and A-1. ### Trading companies close in size

1. [Arisinfra Solutions Ltd](https://www.sectoralpha.in/stocks/arisinfra-solutions-ltd) ₹1,138 crore
2. [Nupur Recyclers Ltd](https://www.sectoralpha.in/stocks/nupur-recyclers-ltd) ₹1,105 crore
3. [Ivalue Infosolutions Ltd](https://www.sectoralpha.in/stocks/ivalue-infosolutions-ltd) ₹1,078 crore
4. BN Agrochem Ltd ₹1,076 crore
5. [Pervasive Commodities Ltd](https://www.sectoralpha.in/stocks/pervasive-commodities-ltd) ₹1,060 crore
6. [Tembo Global Industries Ltd](https://www.sectoralpha.in/stocks/tembo-global-industries-ltd) ₹950 crore
7. [A-1 Ltd](https://www.sectoralpha.in/stocks/a-1-ltd) ₹947 crore

[All 59 Trading companies, largest first](https://www.sectoralpha.in/sectors/trading#all-companies)

### Companies close in size in other industries

1. [Ivalue Infosolutions Ltd](https://www.sectoralpha.in/stocks/ivalue-infosolutions-ltd) ₹1,078 crore · Trading
2. [Arunis Abode Ltd](https://www.sectoralpha.in/stocks/arunis-abode-ltd) ₹1,077 crore · Diversified
3. BN Agrochem Ltd ₹1,076 crore
4. [Yatra Online Ltd](https://www.sectoralpha.in/stocks/yatra-online-ltd) ₹1,076 crore · E-Commerce - Platform - Travel
5. [Excel Industries Ltd](https://www.sectoralpha.in/stocks/excel-industries-ltd) ₹1,074 crore · Pesticides/Agrochemicals

## What else do people ask about BN Agrochem? ### What were BN Agrochem's latest quarterly results? BN Agrochem Ltd reported revenue of ₹258 Cr and net profit of ₹3.0 Cr for the Jun 2026 quarter. Revenue rose 26.7% and profit fell 85.2% compared with a year earlier. Earnings per share were ₹0.30. The operating margin was 2.3%, 9.4 percentage points lower than a year earlier (as of 30 October 2026). ### What is BN Agrochem's market cap? BN Agrochem Ltd's market capitalisation is ₹1,076 Cr at a share price of ₹113.30. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 30 October 2026). ### How is BN Agrochem performing? BN Agrochem Ltd's share price has been falling for 12 weeks. In its latest quarter, revenue rose 26.7% and profit fell 85.2% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 20 weeks running (as of 30 October 2026). ### Will BN Agrochem's share price go up? This page does not forecast BN Agrochem Ltd's share price. What it shows instead: the share price is ₹113.30, and it has been falling for 12 weeks. Its P/E of 63.0× is higher than 33% of its own last 1 years (as of 30 October 2026). ### Who owns BN Agrochem? Promoters own 5.9% of BN Agrochem Ltd, foreign institutions 0.0%, domestic institutions, and the public 94.1% (latest quarter). The biggest change over the last two years: Promoters cut their stake by 52.7 percentage points over 8 quarters (as of 30 October 2026). ### Where is BN Agrochem in its business cycle? BN Agrochem Ltd's FY26 operating margin was 2.6%, against a 3-year range of −44.0% to 2.6%: the middle of its own range, neither a peak nor a low. The latest quarter was 2.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 30 October 2026). ### What could break the BN Agrochem story? The main question: yearly earnings per share moved +74.3% while the share price moved −69.8%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 30 October 2026). ### Is BN Agrochem a stock worth studying right now? What the numbers show: BN Agrochem Ltd's P/E is near the low end of its own history, higher than only 33% of past readings, and its quarterly results are still getting worse. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 30 October 2026). This is research, not advice. We’re not SEBI-registered.